Over 67 million screenings – AstraZeneca's ‘Healthy Heart Africa' celebrates 10 years of transforming Noncommunicable Disease (NCD) care
Hypertension is a leading risk factor for cardiovascular diseases and accounts for a significant portion of noncommunicable disease (NCD) deaths globally. In Africa, over 27% of adults live with hypertension [1], far above the global average.
Since its launch, HHA has conducted over 67 million blood pressure screenings, trained over 11,700 healthcare workers, and activated over 1,550 healthcare facilities across nine African countries in Kenya, Ethiopia, Ghana, Uganda, Côte d'Ivoire, Senegal, Rwanda, Nigeria and Tanzania including the Island of Zanzibar. These efforts have significantly improved access to hypertension diagnosis and treatment, saving countless lives.
Ruud Dobber, Executive Vice President and President, BioPharmaceuticals Business Unit, AstraZeneca, said: 'Healthy Heart Africa epitomises AstraZeneca's commitment to equitable healthcare. In a decade, we've empowered millions to manage their heart health. Now, we've expanded to tackle chronic kidney disease, ensuring greater resilience in health systems across the continent.'
The programme has started addressing chronic kidney disease (CKD), which is closely linked to hypertension and affects 15.8% of Africans. [2] Early detection and management are critical, as CKD often progress silently. HHA aims to improve access to timely diagnosis and treatment, reducing the burden of this disease across communities.
This commemoration sets the stage for the upcoming World Health Organization's High-Level Meeting on NCDs [3], reinforcing the urgency of collective action. One facet of the programme's success is built on strong partnerships with governments, NGOs, and community leaders to deliver culturally tailored interventions.
Helen McGuire, Global Program Leader, PATH, added:
"Working on the Healthy Heart Africa (HHA) programme with AstraZeneca has been truly transformative. Seeing the scale-up and institutionalisation of integrated and expanded NCD services, particularly in countries like Ghana, has been immensely rewarding. The introduction of NCD indicators into national health information systems represents a major milestone, enabling better planning, resource allocation, and outcome monitoring."
Ministries of Health across Africa have championed HHA's integration of hypertension care into national policies, ensuring sustainability and local ownership.
Permanent Secretary Uganda Ministry of Health, Dr Diana Atwine Kanzira, said:
'In Uganda, our partnership with Healthy Heart Africa has been instrumental in strengthening our response to non-communicable diseases (NCDs), now a major health challenge across Africa. Through this collaboration, we have raised awareness on risk factors, enhanced early detection, linked patients to care, and built the capacity of healthcare workers. By integrating hypertension data into our national health system and advancing digitalization, we are ensuring a seamless patient pathway, enabling progress tracking, and delivering life-saving care to our people.'
With its proven model – the Healthy Heart Africa programme aims to expand to new regions, integrating climate-resilient healthcare solutions and prioritising early detection to prevent disease progression. Through such innovative partnerships, the programme aims to deliver care to those most in need.
To read more about this programme, please read our Impact Report here Link (https://apo-opa.co/3QpqSJf).
[1] https://apo-opa.co/41gyyny.
[2] https://apo-opa.co/4b7QzaX
[3] https://apo-opa.co/4jRojxr
AstraZeneca Data on File: Total Programme Numbers Since Start in 2014 to the end of December 2024
Distributed by APO Group on behalf of AstraZeneca.
More about:
Path
PATH is an international non-governmental organisation dedicated to improving health outcomes for vulnerable populations worldwide. Through innovation, partnerships, and a commitment to equity, PATH tackles pressing global health challenges, including non-communicable diseases, maternal and child health, and infectious diseases. Learn more at www.Path.org.
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal&Metabolism, and Respiratory&Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. Please visit AstraZeneca.com and follow the Company on Twitter @ AstraZeneca.
References
[1] https://apo-opa.co/41gyyny.
[2] https://apo-opa.co/4b7QzaX
[3] https://apo-opa.co/4jRojxr
AstraZeneca Data on File: Total Programme Numbers Since Start in 2014 to the end of December 2024
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Web Release
23 minutes ago
- Web Release
Barraquer Eye Hospital UAE Warns Parents About the Hidden Risks of Excessive Screen Time on Children's Vision during back to School preparations
As children across the UAE return to classrooms this month, Barraquer Eye Hospital UAE is urging parents and educators to take a closer look, literally, at the impact of screens on young eyes. With schoolwork increasingly moving online and recreational screen use at an all-time high, eye health experts are raising concerns about a silent but growing epidemic: vision problems in children linked to prolonged digital device use. From completing homework on tablets to chatting with friends on smartphones and watching videos on laptops, children today spend more hours in front of screens than ever before. A recent survey found that more than one-third of children in the UAE spend over seven hours a day using screens, far exceeding the safe limits recommended by the World Health Organization. Myopia, or nearsightedness is one of the most significant concerns linked to sustained near work on devices. According to a 2023 global meta-analysis of more than 335,000 children, each additional hour of daily screen use increases the risk of myopia by 21%. At four or more hours, the risk nearly doubles. 'This is not just about blurred vision,' explains Dr. Alina Mugnani Deza – a Specialist Ophthalmologist for Barraquer Eye Hospital UAE. 'Childhood myopia can progress rapidly, increasing the likelihood of serious eye diseases later in life. With so much learning and leisure happening on screens, parents must be proactive in protecting their children's eyes.' Beyond myopia, prolonged screen exposure can strain the retina due to high-energy blue light emitted by digital devices. While short-term effects include eye strain and disrupted sleep, some studies suggest chronic exposure in children may have longer-term consequences. Computer Vision Syndrome (CVS) is another growing concern, with symptoms such as dry eyes, headaches, blurred vision, and neck pain. Children are particularly vulnerable, as they may hold devices too close to their eyes or forget to take breaks. Barraquer Eye Hospital UAE advises parents and educators to take simple yet effective measures to protect children's vision during the school year. Limiting non-academic screen time—particularly for children under five is an important first step. Encouraging at least one to two hours of outdoor play each day helps reduce the risk of myopia, as natural light plays a protective role in healthy eye development. The hospital also recommends following the 20-20-20 rule, where every 20 minutes of screen use is followed by looking at something 20 feet away for 20 seconds. Adjusting screen settings, such as enabling blue-light filters, increasing font size, and lowering brightness, can further reduce strain. Most importantly, scheduling annual pediatric eye exams ensures that any vision changes are detected early, allowing for timely and effective intervention. 'With the right habits, we can prevent much of the vision damage caused by excessive screen use,' says Dr. Alina Mugnani Deza. 'Parents, teachers, and healthcare providers all have a role in ensuring that today's students can enjoy both the benefits of technology and a lifetime of healthy vision.' As the academic year begins, Barraquer Eye Hospital UAE invites parents to book comprehensive pediatric eye exams to set their children up for visual success—both inside and outside the classroom.
Zawya
a day ago
- Zawya
WHO designates Jeddah and Madinah among 16 'Healthy Cities'
RIYADH — The World Health Organization (WHO) has designated 16 cities as 'Healthy Cities' and two Saudi cities found a place among them, according to the Ministry of Health. Jeddah and Madinah stand out as the first cities in the Middle East with populations of two million to receive the accreditation, marking a key milestone in the ministry's Healthy Cities Program and its ongoing efforts to enhance quality of life. The accomplishment reflects successful collaboration among government and community stakeholders, through the application of more than 80 international evaluation criteria across nine core domains spanning health, development, and sustainability. The ministry noted that the national health system continues to strengthen its global standing through a series of significant achievements in scientific research and international recognition. The Kingdom has also made notable advances in medical research and innovation. A study conducted by King Faisal Specialist Hospital and Research Centre (KFSHRC) on robotic liver transplantation was named one of the top 10 most influential research papers of 2024 by the American Society of Transplantation. In addition, seven Saudi hospitals were included in Brand Finance's Global Top 250 Hospitals 2025 report, highlighting the Kingdom's strong healthcare infrastructure, international competitiveness, and commitment to high-quality patient care. These accomplishments are closely aligned with the objectives of Saudi Vision 2030 — particularly the 'A Vibrant Society' and 'A Thriving Economy' pillars, to enhance quality of life and support innovation and scientific advancement. Together, these milestones reflect the integrated efforts of the national health system and various sectors, reinforcing the Kingdom's position as a regional hub and global destination for advanced healthcare. © Copyright 2022 The Saudi Gazette. All Rights Reserved. Provided by SyndiGate Media Inc. (
Filipino Times
2 days ago
- Filipino Times
WHO warns extended heatwaves pose growing health threat
The World Health Organization (WHO) and climate experts have warned that prolonged heatwaves are no longer a temporary inconvenience but a serious and potentially fatal threat to human health. According to Agence France-Presse (AFP), the danger extends beyond immediate impacts such as heatstroke and severe dehydration. Prolonged exposure can worsen chronic conditions like heart and respiratory diseases, with symptoms, and even deaths, sometimes occurring days after a heatwave begins. French Health Minister Catherine Vautrin urged vigilance in the days following extreme heat, noting that its effects on the body are not always immediate. While earlier studies offered mixed findings on the impact of heatwave duration, with 2011 and 2018 research suggesting only limited cumulative effects, newer studies are revealing broader risks. Reports published in 2024 in The Lancet Countdown and Sleep Medicine described rising temperatures as a 'global threat to sleep,' hampering the body's ability to recover. The warnings recall Europe's 2003 heatwave, which killed more than 70,000 people, underscoring the urgency of addressing extreme heat in the context of accelerating climate change.
